Cipla’s arms complete sale of entire 51.18% stake in CQCIL

15 Nov 2023 Evaluate

Cipla’s wholly owned subsidiaries -- Cipla (EU), UK and Meditab Holdings, Mauritius, have completed the sale of entire 51.18% stake held in Cipla Quality Chemical Industries (CQCIL), Uganda on November 14, 2023 for final consideration amount of $25 million. Accordingly, CQCIL has now ceased to be a subsidiary of the company with effect from November 14, 2023.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1348.55 22.25 (1.68%)
25-Feb-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1762.45
Dr. Reddys Lab 1305.50
Cipla 1348.55
Zydus Lifesciences 919.40
Lupin 2292.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×